

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.28841260 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.28841260 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.10945888 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.00460842 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.00460842 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.00460842 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.00460842 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 6.00460842 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.00460842 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.88323606 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.74819795 |
| 12 | detection of other organism (GO:0098543) | 5.29067631 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.26524639 |
| 14 | response to peptidoglycan (GO:0032494) | 5.18018574 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16631942 |
| 16 | detection of bacterium (GO:0016045) | 5.05945035 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 5.03155527 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.95476527 |
| 19 | cellular extravasation (GO:0045123) | 4.78605337 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.64654983 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.62588889 |
| 22 | neutrophil activation (GO:0042119) | 4.62323876 |
| 23 | leukocyte aggregation (GO:0070486) | 4.61349035 |
| 24 | detection of external biotic stimulus (GO:0098581) | 4.50038484 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.49452001 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.42887641 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.40799053 |
| 28 | respiratory burst (GO:0045730) | 4.40314759 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.28639266 |
| 30 | microglial cell activation (GO:0001774) | 4.27323893 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.16816367 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.14457660 |
| 33 | response to host immune response (GO:0052572) | 4.14457660 |
| 34 | granulocyte activation (GO:0036230) | 4.13837378 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.13094100 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 4.12797547 |
| 37 | neutrophil mediated immunity (GO:0002446) | 4.09478582 |
| 38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.07942343 |
| 39 | response to interleukin-15 (GO:0070672) | 4.03200860 |
| 40 | detection of biotic stimulus (GO:0009595) | 4.02503623 |
| 41 | positive regulation of mast cell activation (GO:0033005) | 3.97130323 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.96093627 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.92887488 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.90537586 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.89806820 |
| 46 | macrophage activation (GO:0042116) | 3.84216891 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.81260009 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 3.77873968 |
| 49 | regulation of mast cell activation (GO:0033003) | 3.74537951 |
| 50 | response to host (GO:0075136) | 3.70942262 |
| 51 | response to host defenses (GO:0052200) | 3.70942262 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.70942262 |
| 53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.70225323 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62142804 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59773963 |
| 56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.59575075 |
| 57 | leukocyte degranulation (GO:0043299) | 3.47983845 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44224325 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 3.44224325 |
| 60 | myeloid leukocyte mediated immunity (GO:0002444) | 3.43753584 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.40423310 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.39192267 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38528020 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.38401023 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37675583 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.37536254 |
| 67 | activated T cell proliferation (GO:0050798) | 3.35294076 |
| 68 | defense response to protozoan (GO:0042832) | 3.29548775 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 3.28941638 |
| 70 | B cell mediated immunity (GO:0019724) | 3.28283185 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.27637972 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.26412700 |
| 73 | type I interferon signaling pathway (GO:0060337) | 3.26412700 |
| 74 | response to type I interferon (GO:0034340) | 3.25068913 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.25038957 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.22600571 |
| 77 | negative regulation of interleukin-6 production (GO:0032715) | 3.21001975 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.19062863 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17699068 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17699068 |
| 81 | negative regulation of interleukin-1 production (GO:0032692) | 3.12610610 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.12440425 |
| 83 | dendritic cell migration (GO:0036336) | 3.12284244 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10670348 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07910344 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 3.06294776 |
| 87 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02979196 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01142601 |
| 89 | dendritic cell chemotaxis (GO:0002407) | 3.00893340 |
| 90 | germinal center formation (GO:0002467) | 3.00746542 |
| 91 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.00670534 |
| 92 | neutrophil chemotaxis (GO:0030593) | 2.99775297 |
| 93 | negative regulation of type 2 immune response (GO:0002829) | 2.98645360 |
| 94 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97826255 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.97231527 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.97024586 |
| 97 | response to protozoan (GO:0001562) | 2.94141274 |
| 98 | myeloid leukocyte activation (GO:0002274) | 2.93519222 |
| 99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92751513 |
| 100 | neutrophil migration (GO:1990266) | 2.92253431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.04617590 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.86933343 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.69855390 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91692114 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85870053 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.38415546 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34164980 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26151305 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03427319 |
| 10 | SPI1_23547873_ChIP-Seq_NB4_Human | 3.01932418 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92554053 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79571561 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.72522382 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67583107 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67338869 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.64813200 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63810617 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.63349847 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60968572 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50921706 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.43676416 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32198829 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23836786 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.21997898 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.20785129 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15907746 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12200071 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08626423 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05532158 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04271814 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.99044205 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98908814 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97814872 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92242565 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88127083 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85456700 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84010359 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71486442 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67066012 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.65019289 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.64862006 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.64439819 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63145048 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60671349 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58701769 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52360940 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52100964 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50630327 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48211846 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47920220 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46317313 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46270809 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44921745 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43180318 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43001355 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41178007 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38408416 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32935245 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32531629 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31543231 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29782672 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29326108 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26015821 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25718835 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25388821 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22102539 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21474062 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19301463 |
| 69 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18760128 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17594170 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14857881 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14418905 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14319614 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12912299 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11657079 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11511802 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09189778 |
| 78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06972208 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05718089 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05036260 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03030534 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01391998 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99939932 |
| 84 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96361744 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92292185 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90973750 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89652243 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89171323 |
| 89 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.88704319 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86148598 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85685464 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83054501 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81701209 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80491824 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80484367 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78386164 |
| 97 | * P300_27268052_Chip-Seq_Bcells_Human | 0.76519752 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76255756 |
| 99 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.72911450 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72746420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.21731232 |
| 2 | MP0003436_decreased_susceptibility_to | 4.29352870 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.98236856 |
| 4 | MP0003303_peritoneal_inflammation | 3.64713621 |
| 5 | MP0002419_abnormal_innate_immunity | 3.35619031 |
| 6 | MP0005671_abnormal_response_to | 3.10507859 |
| 7 | MP0009785_altered_susceptibility_to | 3.07646974 |
| 8 | MP0005025_abnormal_response_to | 3.00288759 |
| 9 | MP0001800_abnormal_humoral_immune | 2.98725533 |
| 10 | MP0000685_abnormal_immune_system | 2.96323154 |
| 11 | MP0001790_abnormal_immune_system | 2.86707186 |
| 12 | MP0005387_immune_system_phenotype | 2.86707186 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.85958818 |
| 14 | MP0006082_CNS_inflammation | 2.75914758 |
| 15 | MP0002723_abnormal_immune_serum | 2.68963066 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.61963958 |
| 17 | MP0001819_abnormal_immune_cell | 2.59327734 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.58930114 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.50484978 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.18745981 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.03610571 |
| 22 | MP0002405_respiratory_system_inflammati | 2.03497099 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.99869353 |
| 24 | MP0002132_abnormal_respiratory_system | 1.97728993 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.92816950 |
| 26 | MP0000716_abnormal_immune_system | 1.91519266 |
| 27 | MP0002398_abnormal_bone_marrow | 1.90544866 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.90230922 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.86727722 |
| 30 | MP0009278_abnormal_bone_marrow | 1.84702273 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.81712989 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.75741874 |
| 33 | MP0009764_decreased_sensitivity_to | 1.73102182 |
| 34 | MP0003828_pulmonary_edema | 1.72848688 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.65827785 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.63926848 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.61993272 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.58296898 |
| 39 | MP0008260_abnormal_autophagy | 1.57350019 |
| 40 | MP0002722_abnormal_immune_system | 1.56139137 |
| 41 | MP0003866_abnormal_defecation | 1.54737443 |
| 42 | MP0008469_abnormal_protein_level | 1.54442236 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.54309372 |
| 44 | MP0002429_abnormal_blood_cell | 1.49554894 |
| 45 | MP0004947_skin_inflammation | 1.43626842 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.41080617 |
| 47 | MP0004381_abnormal_hair_follicle | 1.36178827 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.36025906 |
| 49 | MP0004883_abnormal_blood_vessel | 1.35515810 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.33429109 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.33429109 |
| 52 | MP0005310_abnormal_salivary_gland | 1.30705094 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.30545641 |
| 54 | MP0003075_altered_response_to | 1.27252215 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.13767050 |
| 56 | MP0001851_eye_inflammation | 1.13399762 |
| 57 | MP0000858_altered_metastatic_potential | 1.07160828 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.06592853 |
| 59 | MP0005164_abnormal_response_to | 1.05822498 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.03660814 |
| 61 | MP0005451_abnormal_body_composition | 1.02465167 |
| 62 | MP0003690_abnormal_glial_cell | 0.99530602 |
| 63 | MP0004510_myositis | 0.96758214 |
| 64 | MP0002166_altered_tumor_susceptibility | 0.94492591 |
| 65 | MP0005166_decreased_susceptibility_to | 0.94358858 |
| 66 | MP0001663_abnormal_digestive_system | 0.89688385 |
| 67 | MP0005058_abnormal_lysosome_morphology | 0.86067946 |
| 68 | MP0000343_altered_response_to | 0.86010371 |
| 69 | MP0005390_skeleton_phenotype | 0.85236278 |
| 70 | MP0009763_increased_sensitivity_to | 0.84226296 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.78945427 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.78367115 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.77689928 |
| 74 | MP0008004_abnormal_stomach_pH | 0.77455855 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.75214891 |
| 76 | MP0002928_abnormal_bile_duct | 0.74484239 |
| 77 | MP0001873_stomach_inflammation | 0.74360423 |
| 78 | MP0001853_heart_inflammation | 0.71861458 |
| 79 | MP0003045_fibrosis | 0.71831196 |
| 80 | MP0003448_altered_tumor_morphology | 0.69338664 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.69168560 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.69159624 |
| 83 | MP0003878_abnormal_ear_physiology | 0.69159624 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.69002448 |
| 85 | MP0000604_amyloidosis | 0.68727515 |
| 86 | MP0004130_abnormal_muscle_cell | 0.68597311 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.66978088 |
| 88 | MP0000490_abnormal_crypts_of | 0.65054780 |
| 89 | MP0005083_abnormal_biliary_tract | 0.64215029 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.62520815 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.61100553 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.60984988 |
| 93 | MP0003795_abnormal_bone_structure | 0.57301237 |
| 94 | MP0002006_tumorigenesis | 0.56353317 |
| 95 | MP0002933_joint_inflammation | 0.55515936 |
| 96 | MP0000249_abnormal_blood_vessel | 0.54546618 |
| 97 | MP0003252_abnormal_bile_duct | 0.54234925 |
| 98 | MP0008874_decreased_physiological_sensi | 0.52655323 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.51493966 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.51194191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.57025885 |
| 2 | Myositis (HP:0100614) | 6.34390010 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.30099832 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.16591910 |
| 5 | Orchitis (HP:0100796) | 5.92694850 |
| 6 | Stomatitis (HP:0010280) | 5.77394697 |
| 7 | Optic neuritis (HP:0100653) | 5.69318476 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.69318476 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.56320097 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.31596690 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.09521145 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.49757028 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.34363715 |
| 14 | Obstructive lung disease (HP:0006536) | 4.29795178 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.29795178 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 4.28287112 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.28191161 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 4.22697808 |
| 19 | Meningitis (HP:0001287) | 4.18621292 |
| 20 | Recurrent skin infections (HP:0001581) | 4.17348900 |
| 21 | Encephalitis (HP:0002383) | 4.10748966 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 4.06527841 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.93853911 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.93853911 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.86870854 |
| 26 | Hypochromic anemia (HP:0001931) | 3.61677815 |
| 27 | Urticaria (HP:0001025) | 3.59670170 |
| 28 | Vasculitis (HP:0002633) | 3.56044139 |
| 29 | Increased IgE level (HP:0003212) | 3.41727629 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.37648153 |
| 31 | Episodic fever (HP:0001954) | 3.35069281 |
| 32 | Hemoptysis (HP:0002105) | 3.34288763 |
| 33 | Prolonged bleeding time (HP:0003010) | 3.31934243 |
| 34 | Gingivitis (HP:0000230) | 3.29496313 |
| 35 | Chest pain (HP:0100749) | 3.29386944 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.13688219 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 3.04276847 |
| 38 | Leukocytosis (HP:0001974) | 3.03646793 |
| 39 | Anorexia (HP:0002039) | 2.96775548 |
| 40 | Arterial thrombosis (HP:0004420) | 2.90362726 |
| 41 | Amyloidosis (HP:0011034) | 2.89024798 |
| 42 | T lymphocytopenia (HP:0005403) | 2.86589941 |
| 43 | Cellulitis (HP:0100658) | 2.84393462 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.83105710 |
| 45 | Pulmonary embolism (HP:0002204) | 2.75888853 |
| 46 | Gingival bleeding (HP:0000225) | 2.75612828 |
| 47 | Abnormality of T cells (HP:0002843) | 2.71468254 |
| 48 | Petechiae (HP:0000967) | 2.65636199 |
| 49 | Recurrent viral infections (HP:0004429) | 2.64744381 |
| 50 | Peritonitis (HP:0002586) | 2.63575786 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.63217184 |
| 52 | Pustule (HP:0200039) | 2.61150832 |
| 53 | Granulocytopenia (HP:0001913) | 2.60974610 |
| 54 | Epistaxis (HP:0000421) | 2.59100134 |
| 55 | Microcytic anemia (HP:0001935) | 2.54229730 |
| 56 | Increased IgM level (HP:0003496) | 2.53966826 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.51999834 |
| 58 | Gangrene (HP:0100758) | 2.49515665 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.49299943 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.46425883 |
| 61 | Osteomyelitis (HP:0002754) | 2.44300240 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.43532681 |
| 63 | Sepsis (HP:0100806) | 2.35756368 |
| 64 | Eosinophilia (HP:0001880) | 2.24764642 |
| 65 | Keratitis (HP:0000491) | 2.23541841 |
| 66 | Abnormality of the endocardium (HP:0004306) | 2.19672476 |
| 67 | Vertigo (HP:0002321) | 2.16501000 |
| 68 | Lymphopenia (HP:0001888) | 2.16012207 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14499332 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14231691 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14231691 |
| 72 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14231691 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.13417089 |
| 74 | Chronic otitis media (HP:0000389) | 2.13337316 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.12735109 |
| 76 | Increased serum ferritin (HP:0003281) | 2.09217173 |
| 77 | Purpura (HP:0000979) | 2.06879124 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05730842 |
| 79 | Glomerulopathy (HP:0100820) | 2.05349564 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.04372850 |
| 81 | Abnormality of the pericardium (HP:0001697) | 2.04126856 |
| 82 | Polyneuropathy (HP:0001271) | 2.03197124 |
| 83 | Acne (HP:0001061) | 2.00358242 |
| 84 | Abnormality of the peritoneum (HP:0002585) | 2.00138523 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99686708 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.97912746 |
| 87 | Cheilitis (HP:0100825) | 1.97720427 |
| 88 | Stomach cancer (HP:0012126) | 1.95607947 |
| 89 | Abnormality of eosinophils (HP:0001879) | 1.93958319 |
| 90 | Skin rash (HP:0000988) | 1.93105158 |
| 91 | Skin ulcer (HP:0200042) | 1.92943006 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91156314 |
| 93 | Recurrent pneumonia (HP:0006532) | 1.90601386 |
| 94 | Acute hepatic failure (HP:0006554) | 1.90328844 |
| 95 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89842377 |
| 96 | Loss of speech (HP:0002371) | 1.89546082 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86029221 |
| 98 | Colitis (HP:0002583) | 1.84668867 |
| 99 | Amaurosis fugax (HP:0100576) | 1.83184236 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.81559226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.08878000 |
| 2 | MAP4K1 | 3.59504211 |
| 3 | IRAK4 | 3.35407796 |
| 4 | BLK | 3.25069327 |
| 5 | MAP2K3 | 2.94256104 |
| 6 | FES | 2.87105336 |
| 7 | TYK2 | 2.75869466 |
| 8 | TNK2 | 2.68560193 |
| 9 | CSK | 2.65316508 |
| 10 | GRK6 | 2.43990454 |
| 11 | ERN1 | 2.43044397 |
| 12 | TXK | 2.20578298 |
| 13 | ZAP70 | 2.01699512 |
| 14 | BTK | 1.94745218 |
| 15 | TAOK3 | 1.87971676 |
| 16 | HCK | 1.87089078 |
| 17 | SYK | 1.84685707 |
| 18 | EPHB1 | 1.84175534 |
| 19 | TAOK1 | 1.83895943 |
| 20 | FGR | 1.74597314 |
| 21 | MAP3K3 | 1.73324966 |
| 22 | MAP3K11 | 1.68808811 |
| 23 | JAK3 | 1.67234038 |
| 24 | KIT | 1.65101939 |
| 25 | LYN | 1.57105367 |
| 26 | MAP3K14 | 1.55504813 |
| 27 | CSF1R | 1.48553001 |
| 28 | IKBKE | 1.48505741 |
| 29 | JAK2 | 1.39027066 |
| 30 | PRPF4B | 1.38982886 |
| 31 | SIK3 | 1.38371243 |
| 32 | CDK19 | 1.33185005 |
| 33 | TBK1 | 1.29122943 |
| 34 | LCK | 1.26063767 |
| 35 | TEC | 1.24297066 |
| 36 | ITK | 1.18287339 |
| 37 | IRAK1 | 1.17338271 |
| 38 | MARK3 | 1.16872425 |
| 39 | YES1 | 1.13147341 |
| 40 | MAP3K1 | 1.10894791 |
| 41 | MAP3K13 | 1.10745868 |
| 42 | JAK1 | 1.10322736 |
| 43 | SIK2 | 1.10162008 |
| 44 | MATK | 1.07836911 |
| 45 | IKBKB | 1.04130644 |
| 46 | BMPR2 | 0.98988296 |
| 47 | PRKD2 | 0.95494315 |
| 48 | KSR2 | 0.95424719 |
| 49 | MARK2 | 0.87683136 |
| 50 | PDK1 | 0.86277990 |
| 51 | STK10 | 0.79926809 |
| 52 | DAPK2 | 0.79772314 |
| 53 | PTK6 | 0.79650729 |
| 54 | IRAK2 | 0.78038607 |
| 55 | PTK2B | 0.76484202 |
| 56 | STK11 | 0.73734157 |
| 57 | MAP2K4 | 0.73446131 |
| 58 | FRK | 0.71608641 |
| 59 | PRKCQ | 0.68439280 |
| 60 | PDPK1 | 0.68151037 |
| 61 | PIK3CG | 0.67629337 |
| 62 | MAP3K7 | 0.65424495 |
| 63 | FYN | 0.63967621 |
| 64 | TGFBR2 | 0.63273187 |
| 65 | MAPK12 | 0.60393193 |
| 66 | TAOK2 | 0.59904090 |
| 67 | MAP2K6 | 0.59757162 |
| 68 | GRK7 | 0.59660629 |
| 69 | MAP3K6 | 0.56915720 |
| 70 | MAPK7 | 0.54318306 |
| 71 | TESK2 | 0.53975949 |
| 72 | MAP3K5 | 0.49917957 |
| 73 | EPHA3 | 0.49548487 |
| 74 | MAP3K2 | 0.49196168 |
| 75 | HIPK2 | 0.49030903 |
| 76 | DYRK1B | 0.48359283 |
| 77 | RPS6KA6 | 0.45321435 |
| 78 | LRRK2 | 0.44732932 |
| 79 | RPS6KC1 | 0.42816684 |
| 80 | RPS6KL1 | 0.42816684 |
| 81 | OXSR1 | 0.42367924 |
| 82 | SGK3 | 0.40673553 |
| 83 | NLK | 0.39413371 |
| 84 | CAMKK2 | 0.38782649 |
| 85 | PIM1 | 0.38614486 |
| 86 | STK38 | 0.36439245 |
| 87 | PRKCZ | 0.36363385 |
| 88 | SGK2 | 0.34134052 |
| 89 | ADRBK2 | 0.33598215 |
| 90 | MAPKAPK2 | 0.33363950 |
| 91 | ACVR1B | 0.32330508 |
| 92 | ABL1 | 0.31977220 |
| 93 | PRKCD | 0.30962213 |
| 94 | RAF1 | 0.30531840 |
| 95 | PRKCH | 0.29279253 |
| 96 | CDC42BPA | 0.29239121 |
| 97 | ADRBK1 | 0.28449245 |
| 98 | CAMKK1 | 0.28070814 |
| 99 | DYRK3 | 0.27643912 |
| 100 | FGFR3 | 0.27253575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22095020 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11865331 |
| 3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.06331953 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70585116 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.66181385 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.45755977 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.37608457 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.32997034 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.27882237 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19823938 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.16778154 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07906314 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06189582 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.04181606 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98422909 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.95483214 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86586251 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83138522 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77308005 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77101469 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.71403716 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.70840929 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69229068 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.66141392 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55579271 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53989290 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.53500626 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50334297 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49581273 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49120413 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48962068 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.45973092 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39467811 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38825303 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33644665 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26198840 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24734119 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23843157 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21898682 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.16134684 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07432846 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07317814 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.04756878 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04303372 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03584482 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01852711 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.98887760 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.92119663 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.90763404 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.90591083 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87281627 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.86781852 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86476132 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86097437 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84989757 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84785778 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82953429 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.74721690 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73551514 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67322454 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66845974 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66537561 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.65376858 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65022214 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63974486 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63602103 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60550575 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60123123 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57767798 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57392710 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54848568 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54526460 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54354449 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52744485 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52315374 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51317080 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51195694 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50447141 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46634329 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44814190 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44275817 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44242026 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43421767 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43216217 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42931085 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40817444 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40786736 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.39981345 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38942233 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.37947737 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37008438 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35828456 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35258242 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35024845 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33791875 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32105066 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30802129 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30386825 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28318499 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27537939 |

